VISTN — Vistin Pharma ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK1.06bn
- NOK1.03bn
- NOK438.33m
- 89
- 40
- 74
- 79
Annual cashflow statement for Vistin Pharma ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | — | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 84 | -124 | 32 | -6.01 | 58.5 |
| Depreciation | |||||
| Non-Cash Items | -66.1 | 0 | — | — | — |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -7.93 | -31.1 | -28.9 | -16.8 | 12.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 18.9 | -146 | 13.7 | -10.5 | 88.1 |
| Capital Expenditures | -18.4 | -53.1 | -31.9 | -64.3 | -17.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 1.73 | 0.265 | 0.028 | — |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -18.4 | -51.4 | -31.7 | -64.3 | -17.9 |
| Financing Cash Flow Items | -0.268 | -0.753 | -0.289 | -2.09 | -45.5 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.64 | -45.5 | -23.3 | 40.5 | -45.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.06 | -243 | -41.3 | -34.3 | 24.8 |